Department of Surgery, Division of Surgical Oncology, Allegheny Health Network, Pittsburgh, PA, USA.
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ann Surg Oncol. 2022 Oct;29(11):6537-6545. doi: 10.1245/s10434-022-11534-z. Epub 2022 Apr 7.
We measured the importance patients with gastrointestinal cancer and health care providers place on treatment outcomes, quality of life, and costs.
This cross-sectional survey study was conducted between June 1, 2020 and November 30, 2020. We identified surviving patients who had been treated or were anticipating treatment for pancreatic or gastric cancer at our single institution from January 1, 2000 through January 31, 2020. Surveys assessed the importance patients and providers placed on outcomes, well-being, costs, and experiences. Surveys measured how these values had changed over time. We compared the importance patients and providers place on each of the attributes of value.
A total of 383 patients and 164 providers responded. Providers felt experience, emotional well-being, and costs were more important than patients themselves did (all p < 0.05). Patients more commonly reported that survival had become more important to them over time, while providers believed that emotional well-being, experience, and costs had become more important to patients (all p < 0.05). Postoperative patients ranked functional well-being as more important than preoperative patients did (p = 0.031). Patients of lower income and education levels more reported concerns of costs over the course of their care (both p < 0.05). Younger age was associated with concern for direct (r = -0.167, p = 0.004) and indirect costs (r = -0.318, p < 0.001).
Although there are consistencies amongst the views of cancer patients and providers, there remain discordances in the perception of value. Patients' values differed across their treatment and survivorship course. These data demonstrate the importance of accounting for multistakeholder perspectives in assessments of value in health care.
我们衡量了胃肠道癌症患者和医疗保健提供者对治疗结果、生活质量和成本的重视程度。
本横断面调查研究于 2020 年 6 月 1 日至 2020 年 11 月 30 日进行。我们从 2000 年 1 月 1 日至 2020 年 1 月 31 日在我们的单家机构中确定了接受过治疗或预计接受胰腺或胃癌治疗的幸存患者。调查评估了患者和提供者对结果、幸福感、成本和体验的重视程度。调查衡量了这些价值观随时间的变化。我们比较了患者和提供者对每个价值属性的重视程度。
共有 383 名患者和 164 名提供者做出了回应。提供者认为经验、情绪健康和成本比患者本身更重要(均 p < 0.05)。患者更常报告说,随着时间的推移,生存对他们变得更加重要,而提供者则认为情绪健康、经验和成本对患者变得更加重要(均 p < 0.05)。术后患者将功能健康列为比术前患者更重要(p = 0.031)。较低收入和教育水平的患者在治疗过程中更关注成本问题(均 p < 0.05)。年龄较小与对直接(r = -0.167,p = 0.004)和间接成本(r = -0.318,p < 0.001)的担忧相关。
尽管癌症患者和提供者的观点存在一致性,但在对价值的看法上仍存在差异。患者的价值观在治疗和生存过程中存在差异。这些数据表明,在医疗保健中评估价值时,考虑多方利益相关者的观点非常重要。